Alumis ALMS
NASDAQ ALMS
$9.90 +0.10 (+1.02%)
At close: Sep 10, 2026 · 4:00 PM EDT

Alumis (ALMS) Shares Outstanding (2023 - 2026)

Alumis' (ALMS) quarterly Shares Outstanding (Entity) came in at $124.4 million in Q2 2026, up 62.55% year-over-year from $76.6 million in Q2 2025, and up 25.6% quarter-over-quarter from $99.1 million in Q4 2025.

Analysis

Alumis (ALMS) Shares Outstanding (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Shares Outstanding (Entity) for 4 consecutive years, with $124.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 62.55% year-over-year to $124.4 million in Q2 2026; TTM through Jun 2026 was $124.4 million, a 62.55% increase from a year earlier, with the FY2025 full-year figure at $99.1 million, up 246.69% from the prior year.
  • Shares Outstanding (Entity) was $124.4 million for Q2 2026 at Alumis, up from $99.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $124.4 million in Q2 2026 and troughed at $5.4 million in Q2 2023.
  • A 4-year average of $46.3 million and a median of $37.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) jumped 782.33% in 2024 and jumped 62.55% in 2026, its largest moves.
  • Over 4 years, Shares Outstanding (Entity) stood at $5.4 million in 2023, then soared by 434.01% to $28.6 million in 2024, then soared by 246.69% to $99.1 million in 2025, then gained by 25.6% to $124.4 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $124.4 million (Q2 2026), $99.1 million (Q4 2025), and $97.2 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 61.30 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 720.78 Mn
10 Alumis 1.27 Bn 765.76 Mn - 127.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.70 Mn
Dec 31, 2025 85.10 Mn
Sep 30, 2025 104.15 Mn
Jun 30, 2025 76.56 Mn
Mar 31, 2025 54.41 Mn
Dec 31, 2024 28.58 Mn
Sep 30, 2024 53.97 Mn
Jun 30, 2024 2.70 Mn
Mar 31, 2024 2.68 Mn
Dec 31, 2023 2.65 Mn
Sep 30, 2023 2.65 Mn
Jun 30, 2023 2.64 Mn